CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
56.88
-1.30 (-2.23%)
At close: Dec 5, 2025, 4:00 PM EST
57.17
+0.29 (0.52%)
After-hours: Dec 5, 2025, 7:59 PM EST
CRISPR Therapeutics AG Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5,421 | 3,360 | 4,972 | 3,183 | 5,799 | 10,818 | |
| Market Cap Growth | 34.27% | -32.44% | 56.24% | -45.12% | -46.39% | 198.74% | |
| Enterprise Value | 3,688 | 1,651 | 3,474 | 1,452 | 3,527 | 9,501 | |
| Last Close Price | 56.88 | 39.36 | 62.60 | 40.65 | 75.78 | 153.11 | |
| PE Ratio | - | - | - | - | 15.36 | - | |
| PS Ratio | 129.76 | 90.03 | 13.40 | 2656.64 | 6.34 | 15045.33 | |
| PB Ratio | 2.79 | 1.74 | 2.64 | 1.70 | 2.42 | 6.50 | |
| P/TBV Ratio | 2.83 | 1.74 | 2.64 | 1.70 | 2.42 | 6.50 | |
| P/FCF Ratio | - | - | - | - | 12.68 | - | |
| P/OCF Ratio | - | - | - | - | 10.76 | - | |
| EV/Sales Ratio | 96.19 | 44.26 | 9.36 | 1211.76 | 3.86 | 13213.93 | |
| EV/EBITDA Ratio | - | - | - | - | 9.01 | - | |
| EV/EBIT Ratio | - | - | - | - | 9.44 | - | |
| EV/FCF Ratio | - | - | - | - | 7.71 | - | |
| Debt / Equity Ratio | 0.11 | 0.12 | 0.13 | 0.13 | 0.09 | 0.04 | |
| Debt / EBITDA Ratio | - | - | - | - | 0.53 | - | |
| Debt / FCF Ratio | - | - | - | - | 0.49 | - | |
| Asset Turnover | 0.02 | 0.02 | 0.17 | 0 | 0.40 | 0 | |
| Quick Ratio | 16.10 | 22.00 | 17.47 | 15.08 | 19.92 | 18.05 | |
| Current Ratio | 16.22 | 22.07 | 17.54 | 15.30 | 20.17 | 18.21 | |
| Return on Equity (ROE) | -25.33% | -19.20% | -8.17% | -30.42% | 18.59% | -26.80% | |
| Return on Assets (ROA) | -13.28% | -13.04% | -6.22% | -16.85% | 10.20% | -15.30% | |
| Return on Capital (ROIC) | -13.92% | -13.63% | -6.56% | -17.74% | 10.73% | -16.30% | |
| Return on Capital Employed (ROCE) | -22.50% | -21.70% | -10.50% | -31.70% | 14.20% | -20.40% | |
| Earnings Yield | -9.01% | -10.90% | -3.09% | -20.43% | 6.51% | -3.23% | |
| FCF Yield | -5.59% | -4.31% | -5.43% | -16.74% | 7.89% | -2.37% | |
| Buyback Yield / Dilution | -5.48% | -6.49% | -1.90% | 3.29% | -21.90% | -15.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.